hVIVO plc (LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has announced that it will release its audited final results for the twelve months ended 31 December 2022 on Tuesday 25 April 2023.
hVIVO reports revenue surge and expanding growth prospects
Specialist research group hVIVO has seen a significant rise in revenue for the first half of 2024, recording a 30.6% increase compared to the same period last year. The company generated £35.6 million in the first